CLINICAL TRIALS PROFILE FOR PIMAVANSERIN
✉ Email this page to a colleague
All Clinical Trials for PIMAVANSERIN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00477672 ↗ | A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis | Completed | ACADIA Pharmaceuticals Inc. | Phase 3 | 2007-06-01 | This study will evaluate the safety and efficacy of two dose levels of pimavanserin (ACP-103) compared to placebo in patients with Parkinson's disease psychosis. |
NCT00550238 ↗ | A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis | Completed | ACADIA Pharmaceuticals Inc. | Phase 3 | 2007-07-01 | To assess the long-term safety and tolerability of ACP-103 in subjects with Parkinson's disease psychosis. |
NCT00658567 ↗ | A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis | Completed | ACADIA Pharmaceuticals Inc. | Phase 3 | 2008-03-01 | This study will evaluate the safety and efficacy of two dose levels of pimavanserin (ACP-103) compared to placebo in patients with Parkinson's disease psychosis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PIMAVANSERIN
Condition Name
Clinical Trial Locations for PIMAVANSERIN
Trials by Country
Clinical Trial Progress for PIMAVANSERIN
Clinical Trial Phase
Clinical Trial Sponsors for PIMAVANSERIN
Sponsor Name